Iboxamycin
Modify Date: 2024-01-02 11:34:41
Iboxamycin structure
|
Common Name | Iboxamycin | ||
|---|---|---|---|---|
| CAS Number | 2640000-92-4 | Molecular Weight | 495.07 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H39ClN2O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IboxamycinIboxamycin is a potent antibiotic candidate bearing a fused bicyclic amino acid residue. Iboxamycin is orally bioavailable, safe and effective in treating both Gram-positive and Gram-negative bacterial infections in mice[1][2]. |
| Name | Iboxamycin |
|---|
| Description | Iboxamycin is a potent antibiotic candidate bearing a fused bicyclic amino acid residue. Iboxamycin is orally bioavailable, safe and effective in treating both Gram-positive and Gram-negative bacterial infections in mice[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Iboxamycin is effective against ESKAPE pathogens including strains expressing Erm and Cfr ribosomal RNA methyltransferase enzymes, products of genes that confer resistance to all clinically relevant antibiotics targeting the large ribosomal subunit, namely macrolides, lincosamides, phenicols, oxazolidinones, pleuromutilins and streptogramins[2]. |
| References |
| Molecular Formula | C22H39ClN2O6S |
|---|---|
| Molecular Weight | 495.07 |